Publicacións nas que colabora con Sergio Raposeiras Roubín (22)

2023

  1. Bleeding and embolic risk in patients with atrial fibrillation and cancer

    Revista Espanola de Cardiologia, Vol. 76, Núm. 5, pp. 344-352

  2. Left Ventricular Assist Device as a Destination Therapy: Current Situation and the Importance of Patient Selection

    Life, Vol. 13, Núm. 4

  3. Socioeconomic variations determine the clinical presentation, aetiology, and outcome of infective endocarditis: a prospective cohort study from the ESC-EORP EURO-ENDO (European Infective Endocarditis) registry

    European Heart Journal - Quality of Care and Clinical Outcomes, Vol. 9, Núm. 1, pp. 85-96

2022

  1. Characteristics, management, and outcomes of patients with left-sided infective endocarditis complicated by heart failure: a substudy of the ESC-EORP EURO-ENDO (European infective endocarditis) registry

    European Journal of Heart Failure, Vol. 24, Núm. 7, pp. 1253-1265

  2. Nutrition status, obesity and outcomes in patients with atrial fibrillation

    Revista Espanola de Cardiologia, Vol. 75, Núm. 10, pp. 826-833

  3. Trade-off between the effects of embolic versus bleeding events on mortality in elderly patients with atrial fibrillation

    Revista Espanola de Cardiologia, Vol. 75, Núm. 4, pp. 334-342

  4. Validation of Embolic and Bleeding Risk Scores in Patients With Atrial Fibrillation and Cancer

    American Journal of Cardiology, Vol. 180, pp. 44-51

2020

  1. Impact of anticoagulation in patients with dementia and atrial fibrillation. Results of the CardioCHUVI-FA registry

    Revista Espanola de Cardiologia, Vol. 73, Núm. 11, pp. 877-884

  2. Impact of malnutrition in the embolic-haemorrhagic trade-off of elderly patients with atrial fibrillation

    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, Vol. 22, Núm. 6, pp. 878-887

  3. Incidence, predictors and prognostic impact of intracranial bleeding within the first year after an acute coronary syndrome in patients treated with percutaneous coronary intervention

    European Heart Journal: Acute Cardiovascular Care, Vol. 9, Núm. 7, pp. 764-770

  4. New Cancer Diagnosis After Bleeding in Anticoagulated Patients With Atrial Fibrillation

    Journal of the American Heart Association, Vol. 9, Núm. 22, pp. e016836

  5. Prevalence and Prognostic Significance of Malnutrition in Patients With Acute Coronary Syndrome

    Journal of the American College of Cardiology, Vol. 76, Núm. 7, pp. 828-840

  6. Vitamin K Antagonists and Direct Oral Anticoagulants in Nonagenarian Patients With Atrial Fibrillation

    Journal of the American Medical Directors Association, Vol. 21, Núm. 3, pp. 367-373.e1

2019

  1. Renin–Angiotensin System Blockade and Risk of Heart Failure After Myocardial Infarction Based on Left Ventricular Ejection Fraction: A Retrospective Cohort Study

    American Journal of Cardiovascular Drugs, Vol. 19, Núm. 5, pp. 487-495

  2. Risk of cancer after an acute coronary syndrome according to the type of P2Y12 inhibitor

    Thrombosis Research, Vol. 174, pp. 51-58

2014

  1. Contrast-induced nephropathy and bleeding: A bidirectional link with prognostic value in acute coronary syndrome

    International Journal of Cardiology, Vol. 176, Núm. 1, pp. 235-236

2013

  1. Cambios electrocardiográficos durante la prueba de esfuerzo en un paciente con patrón electrocardiográfico tipo 1 de Brugada: Una curiosidad con implicaciones clínicas

    Revista Espanola de Anestesiologia y Reanimacion

  2. GRACE risk score predicts contrast-induced nephropathy in patients with acute coronary syndrome and normal renal function

    Angiology, Vol. 64, Núm. 1, pp. 31-39

  3. High-sensitivity C-reactive protein predicts adverse outcomes after non-ST-segment elevation acute coronary syndrome regardless of GRACE risk score, but not after ST-segment elevation myocardial infarction

    Revista Portuguesa de Cardiologia, Vol. 32, Núm. 2, pp. 117-122

2012

  1. Is glycated hemoglobin an accurate enough predictor of subclinical myocardial injury or a simple precursor of advanced glycation end products?

    Journal of the American College of Cardiology